Huntington’s disease: novel therapeutic strategies targeting the mutant huntingtin production pathway

L'accès à l'intégralité du contenu de ce site est reservé uniquement aux professionnels de santé disposant d'un compte. Inscrivez-vous gratuitement
No disease-slowing treatment exists for Huntington’s disease, but its monogenic inheritance makes it an appealing candidate for the development of therapies targeting processes close to its genetic cause. Huntington’s disease is caused by CAG repeat expansions in the HTT gene, which encodes t...